Krishna Institute of Medical Sciences Limited KIMS
NSE · India · Health Services
INR 736.25-10.15 (-1.36%)
Market closed· · INR · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · INR · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
KIMS reports 36.1% YoY revenue surge to INR 1,196 crore, driven by new hospital ramp-ups and robust patient volumes, while PAT declines on increased operational costs.
Despite impressive revenue growth, Krishna Institute of Medical Sciences Ltd faces declining margins and profitability hurdles in Q4 FY26.
Despite impressive revenue and IP volume growth, Krishna Institute of Medical Sciences Ltd (BOM:543308) faces profitability pressures with declining EBITDA margins and EPS.
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.